Net Loss Per Common Share
|Nine Months Ended September 30,|
|Shares issuable upon:||2021||2020|
|Conversion of Series A Common Equivalent Preferred Stock||6,665,841||—|
|Exercise of stock options||3,961,959||3,416,345|
|Exercise of common stock warrants||797,487||956,552|
|Vesting of PSUs and RSUs||861,638||496,592|
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Acutus Medical, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - June 24, 2022
Acutus Medical, Inc. director just disposed of 60,000 shares - June 3, 2022
Acutus Medical, Inc.'s Chief Financial Officer just picked up 100,000 shares - June 2, 2022